Use of Technetium-99m-Labeled Lipophilic Complex of Methoxy-Isobutyl-Isonitrile and Iopromide Radiopaque Substance to Assess the Severity of Coronary Atherosclerosis in Patients with Coronary Heart Disease at Mild Disorders of Myocardial Perfusion; Advanced Materials Research : Radiation and nuclear techniques in material science; Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014)

Use of Technetium-99m-Labeled Lipophilic Complex of Methoxy-Isobutyl-Isonitrile and Iopromide Radiopaque Substance to Assess the Severity of Coronary Atherosclerosis in Patients with Coronary Heart Disease at Mild Disorders of Myocardial Perfusion; Advanced Materials Research : Radiation and nuclear techniques in material science; Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014)

Bibliographic Details
Parent link:Advanced Materials Research : Radiation and nuclear techniques in material science: Scientific Journal
Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014).— 2015.— [P. 527-531]
Corporate Authors: Национальный исследовательский Томский политехнический университет (ТПУ) Физико-технический институт (ФТИ) Лаборатория № 31 ядерного реактора (Лаборатория № 31 ЯК), Национальный исследовательский Томский политехнический университет (ТПУ) Физико-технический институт (ФТИ) Кафедра иностранных языков физико-технического института (ИЯФТ)
Other Authors: Zavadovsky K. V. Konstantin Valerievich, Gulya M. O. Marina Olegovna, Lishmanov Yu. B. Yury Borisovich, Verkhoturova V. V. Vera Viktorovna
Summary:Title screen
In this study we used technetium-99m-labeled lipophilic complex of methoxy-isobutyl-isonitrile ({99m}Tc-MIBI) and iopromide to assess coronary atherosclerosis in patients with coronary artery disease (CAD). The study included 33 patients with CAD who underwent myocardial perfusion scintigraphy with {99m}Tc-MIBI and computed tomography angiography (MDCTA) with iopromide. Patients who have comparable with the population-wide level risk of coronary events are characterized by the presence of borderline and significant stenosis 83% and 86%, respectively. {99m}Tc-MIBI and iopromide can be used to assess the severity of coronary atherosclerosis in patients with CAD.
Режим доступа: по договору с организацией-держателем ресурса
Language:English
Published: 2015
Series:Radiation Technologies in Medicine
Subjects:
электронный ресурс
труды учёных ТПУ
ишемическая болезнь
сердце
атеросклероз
Online Access:http://dx.doi.org/10.4028/www.scientific.net/AMR.1084.527
Format: Electronic Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=640437

Similar Items

Similar Items